3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
23
Recruiting
6
Terminated
5
Withdrawn
3
Unknown
3
Active not recruiting
2
Suspended
1
Not yet recruiting
1
Enrolling by invitation
1
Sponsor Class
OTHER
2
INDUSTRY
1
Study Type
Observational
2
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
2
CNS
1
Conditions
Prostatic Neoplasms
9
Glioblastoma
9
Carcinoma, Non-Small-Cell Lung
7
Lung Neoplasms
6
Brain Neoplasms
6
Glioma
5
Breast Neoplasms
5
Oligodendroglioma
4
Neoplasm Metastasis
4
Multiple Myeloma
4
Colorectal Neoplasms
4
Astrocytoma
4
Squamous Cell Carcinoma of Head and Neck
3
Pancreatic Neoplasms
3
Neuroectodermal Tumors, Primitive
3
Neoplasms
3
Meningioma
3
Medulloblastoma
3
Gliosarcoma
3
Glioma, Subependymal
3
Ependymoma
3
Central Nervous System Neoplasms
3
Carcinoma, Renal Cell
3
Sarcoma
2
Platinum-Refractory Fallopian Tube Carcinoma
2
Pinealoma
2
Melanoma
2
Lymphoma, Mantle-Cell
2
Lymphoma
2
Hematologic Neoplasms
2
Interventions
Cisplatin
9
pembrolizumab
7
Radiosurgery
6
Gemcitabine
6
Paclitaxel
5
Dexamethasone
5
Taxes
4
Carboplatin
4
trametinib
3
ibrutinib
3
Surveys and Questionnaires
3
Standard of Care
3
Radiotherapy
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Lenalidomide
3
Fluorouracil
3
Erlotinib Hydrochloride
3
Blood Specimen Collection
3
Ascorbic Acid
3
venetoclax
2
veliparib
2
tocilizumab
2
pazopanib
2
obinutuzumab
2
naquotinib
2
lenvatinib
2
fludarabine
2
enzalutamide
2
Vemurafenib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Withdrawn
×
Neoplasms
×
Magnetic Resonance Spectroscopy
×
Clear all
NCT06390657
2025-05-11
S-C-PATHY
EBG MedAustron GmbH
Withdrawn
NCT04023240
2024-08-12
68-Ga-FAPI PET Imaging in Malignancy
Stanford University
Phase 2
Withdrawn
NCT00645385
2019-06-04
Gliadel-MRS
Weill Medical College of Cornell University
Withdrawn